EKF Diagnostics' COVID-SeroKlir test kit

EKF introduces accurate quantitative Covid-19 antibody test kit

Global in vitro diagnostics company EKF Diagnostics have announced it has introduced to market one of the first tests to precisely measure levels of Covid-19 neutralising antibodies in individuals.

Unlike other antibody tests, the company’s Kantaro COVID-SeroKlir SARS-CoV-2 IgG antibody test kit determines both the presence and specific quantities of Covid-19 antibodies.

This allows for the gathering of a wide range of useful information, which can be used to further understand protective immunity to the virus, assess vaccine response and accelerate therapeutic treatments.

The COVID-SeroKlir test kit has already received FDA Emergency Use Authorisation (EUA) and is CE marked.

In testing, it showed to have 98.8% sensitivity and 99.6% specificity for detecting Covid-19 antibodies against two different strains of the virus antigens. This helps to minimise the risk of false positives and false negatives.

The test achieves this accuracy using a two-step process called an enzyme-linked immunosorbent assay (ELISA). In this process, the ELISA’s initial plate screens for one type of Covid-19 antigen, while the second plate provides a quantitative result checking against the second virus antigen type.

Using standard methods and equipment, the kit is also easily operated without need for scaled equipment or special environments, and contains components to test up to 630 patient samples.

COVID-SeroKlir has been validated on a highly-diverse cohort of more than 75,000 patients, including over 30,000 who were diagnosed with Covid-19 (more than in any other Covid-19 test), as part of a study at the Icahn School of Medicine at Mount Sinai Health System in New York.

The findings of this study were then independently verified by peer-reviewed journals and the US National Institutes of Health (NIH).

The Mount Sinai study demonstrated that over 90% of infected individuals with mild-to-moderate Covid-19 experience robust antibody responses against the viral spike protein – and these Covid-19 neutralising antibody levels were confirmed to be relatively stable during the first five months after infection.

Explaining the value of knowing the precise levels of Covid-19 antibodies in people, Julian Baines, CEO of EKF, said: “Quantitative IgG antibody testing can provide important support for determining public health strategies, informing healthcare decision making, and verifying the effectiveness of vaccines as they become available.

“It is also an essential component of a general health check to determine past Covid-19 infections.

“This is because Covid-19 has been linked with an increased risk of potentially life-threatening complications, including lung, kidney, and cardiovascular disease.”

NHE Nov/Dec 2023

NHE Nov/Dec 2023

AI is key in helping dementia patients live independently for longer.

The Nov/Dec 2023 edition of NHE brings you expert comment and analysis on a range of key health sector topics, from digital transformation to navigating post-pandemic challenges.


View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Events

NHE has created a full calendar of events to address the most important issues that influence the delivery of healthcare services. Over 365 days you'll have the opportunity to hear from a range of highly motivating, informative and inspirational speakers. These speakers will equip you with the knowledge and unique insight to enable you to overcome the challenges that you face.

National Health Executive Podcast

Ep 39.
What makes a good NHS manager? with Anthony Painter, Director of Policy at Chartered Management Institute (CMI)

In episode 39 of the National Health Executive podcast, we were joined by Anthony Painter, who is the director of policy at the Chartered Management Institute (CMI), to discuss all things management within the UK health sector and NHS.

During the podcast, Anthony shared some of the recent research CMI conducted in partnership with the Social Market Foundation, which centred around the state of management and leadership within the NHS.

More articles...

View all